Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been given a prescription for a medication called zuranolone through a specific pharmacy called Accredo Specialty Pharmacy.
- You have had a pregnancy in the last 12 months.
- You have been diagnosed with postpartum depression (PPD).
- You are able to fill out questionnaires on your own, in English.
Who may not be able to join:
- You have already picked up or filled a prescription for zuranolone or a similar medication called brexanolone in the last 12 months.
- You have already taken one or more doses of zuranolone by the time you are screened for the study.
- You currently have or have previously been diagnosed with bipolar disorder.
- You did not complete the first set of surveys at the start of the study (Day 0).
- You did not agree to give your consent to participate.
- Your pregnancy ended more than 12 months ago.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change From Baseline in the Edinburgh Postnatal Depression Scale (EPDS) Score at Day 15
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.